4.56
price up icon0.44%   0.02
after-market アフターアワーズ: 4.55 -0.010 -0.22%
loading
前日終値:
$4.54
開ける:
$4.575
24時間の取引高:
4.71M
Relative Volume:
0.71
時価総額:
$985.77M
収益:
$76.20M
当期純損益:
$-17.37M
株価収益率:
501.10
EPS:
0.0091
ネットキャッシュフロー:
$-75.81M
1週間 パフォーマンス:
+7.29%
1か月 パフォーマンス:
-2.56%
6か月 パフォーマンス:
+33.72%
1年 パフォーマンス:
+622.09%
1日の値動き範囲:
Value
$4.39
$4.66
1週間の範囲:
Value
$4.16
$4.66
52週間の値動き範囲:
Value
$0.61
$8.21

Cytomx Therapeutics Inc Stock (CTMX) Company Profile

Name
名前
Cytomx Therapeutics Inc
Name
セクター
Healthcare (1112)
Name
電話
650.515.3185
Name
住所
151 OYSTER POINT BLVD., SOUTH SAN FRANCISCO, CA
Name
職員
69
Name
Twitter
@cytomxinc
Name
次回の収益日
2026-03-16
Name
最新のSEC提出書
Name
CTMX's Discussions on Twitter

Compare CTMX vs VRTX, REGN, ARGX, ALNY, ONC

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
CTMX icon
CTMX
Cytomx Therapeutics Inc
4.56 981.44M 76.20M -17.37M -75.81M 0.0091
VRTX icon
VRTX
Vertex Pharmaceuticals Inc
441.70 113.01B 12.07B 3.95B 3.19B 15.33
REGN icon
REGN
Regeneron Pharmaceuticals Inc
753.93 79.87B 14.34B 4.50B 3.77B 41.56
ARGX icon
ARGX
Argen X Se Adr
840.87 51.51B 4.16B 1.29B 734.26M 19.58
ALNY icon
ALNY
Alnylam Pharmaceuticals Inc
333.39 45.29B 3.71B 313.75M 465.38M 2.2571
ONC icon
ONC
Beone Medicines Ltd Adr
319.94 34.41B 5.36B 287.73M 924.18M 2.5229

Cytomx Therapeutics Inc Stock (CTMX) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2026-03-16 アップグレード JP Morgan Neutral → Overweight
2026-01-20 開始されました Guggenheim Buy
2025-09-22 開始されました Cantor Fitzgerald Overweight
2025-09-17 再開されました Barclays Overweight
2025-07-31 開始されました Oppenheimer Outperform
2025-05-15 アップグレード H.C. Wainwright Neutral → Buy
2025-04-14 再開されました Piper Sandler Overweight
2024-05-28 アップグレード Piper Sandler Neutral → Overweight
2024-05-09 アップグレード Wedbush Neutral → Outperform
2024-05-06 アップグレード Jefferies Hold → Buy
2024-04-22 アップグレード JP Morgan Underweight → Neutral
2022-11-14 ダウングレード BMO Capital Markets Outperform → Market Perform
2022-07-07 ダウングレード Jefferies Buy → Hold
2022-07-07 ダウングレード Mizuho Buy → Neutral
2022-07-07 ダウングレード Piper Sandler Overweight → Neutral
2022-07-07 ダウングレード Wedbush Outperform → Neutral
2022-06-24 開始されました BMO Capital Markets Outperform
2022-01-18 アップグレード Barclays Underweight → Overweight
2021-11-15 開始されました BTIG Research Buy
2021-05-28 ダウングレード Barclays Equal Weight → Underweight
2021-03-29 開始されました JP Morgan Overweight
2021-03-23 アップグレード Jefferies Hold → Buy
2020-09-22 ダウングレード Guggenheim Buy → Neutral
2020-06-01 ダウングレード Jefferies Buy → Hold
2020-05-14 繰り返されました H.C. Wainwright Buy
2020-03-24 アップグレード Wedbush Neutral → Outperform
2020-03-04 開始されました Barclays Equal Weight
2019-11-20 開始されました Guggenheim Buy
2019-11-11 ダウングレード Wedbush Outperform → Neutral
2019-06-13 開始されました Mizuho Buy
2019-05-14 開始されました Cantor Fitzgerald Overweight
2019-03-11 開始されました Barclays Overweight
2018-11-26 開始されました Piper Jaffray Overweight
2018-10-15 開始されました Goldman Neutral
2018-09-13 開始されました H.C. Wainwright Buy
2018-06-01 開始されました SunTrust Buy
2018-01-05 開始されました Citigroup Buy
2017-09-08 開始されました Wedbush Outperform
2017-03-27 開始されました H.C. Wainwright Buy
2017-03-02 開始されました Instinet Buy
2017-01-03 ダウングレード Oppenheimer Outperform → Perform
2015-11-02 開始されました Oppenheimer Outperform
すべてを表示

Cytomx Therapeutics Inc (CTMX) 最新ニュース

pulisher
Apr 15, 2026

Analysts bullish on CytomX Therapeutics (CTMX) as CTMX prices $250 million offering - MSN

Apr 15, 2026
pulisher
Apr 15, 2026

CytomX Therapeutics (CTMX) making progress on key metastatic colorectal cancer treatment - MSN

Apr 15, 2026
pulisher
Apr 14, 2026

CytomX Therapeutics, Inc. (CTMX) A Top Healthcare Penny Stock Amid Colorectal Cancer Treatment Progress - Insider Monkey

Apr 14, 2026
pulisher
Apr 14, 2026

CytomX Therapeutics (CTMX) gains analyst confidence on trial progress - MSN

Apr 14, 2026
pulisher
Apr 12, 2026

Analysts Bullish on CytomX Therapeutics (CTMX) As CTMX Prices $250 Million Offering - Insider Monkey

Apr 12, 2026
pulisher
Apr 11, 2026

10 Stocks Under $5 That Will Explode - Insider Monkey

Apr 11, 2026
pulisher
Apr 10, 2026

How The CytomX Therapeutics (CTMX) Story Is Shifting With New Colorectal Cancer Data - Yahoo Finance

Apr 10, 2026
pulisher
Apr 07, 2026

Jefferies raises CytomX Therapeutics (CTMX) price target to $16 - MSN

Apr 07, 2026
pulisher
Apr 07, 2026

CytomX Therapeutics, Inc. (CTMX) latest stock news and headlines - Yahoo Finance Singapore

Apr 07, 2026
pulisher
Apr 06, 2026

CytomX Therapeutics (CTMX) Making Progress on Key Metastatic Colorectal Cancer Treatment - Insider Monkey

Apr 06, 2026
pulisher
Apr 05, 2026

CytomX Therapeutics, Inc. (NASDAQ:CTMX) Given Average Rating of "Moderate Buy" by Brokerages - marketbeat.com

Apr 05, 2026
pulisher
Apr 04, 2026

Latest CTMX ETF News Today | Earnings, Events & Price Alerts - Intellectia AI

Apr 04, 2026
pulisher
Apr 04, 2026

CTMX Technical Analysis & ETF Price Forecast - Intellectia AI

Apr 04, 2026
pulisher
Apr 03, 2026

CytomX Therapeutics (CTMX) price target increased by 47.30% to 13.90 - MSN

Apr 03, 2026
pulisher
Apr 02, 2026

CTMX Stock Chart | CYTOMX THERAPEUTICS INC (NASDAQ:CTMX) - ChartMill

Apr 02, 2026
pulisher
Apr 01, 2026

Jefferies Maintains Buy for CTMX (CytomX Therapeutics) March 18, 2026 - Meyka

Apr 01, 2026
pulisher
Apr 01, 2026

CytomX Therapeutics Signals Progress in Varseta-M Trial - TipRanks

Apr 01, 2026
pulisher
Apr 01, 2026

Aug Update: Does CytomX Therapeutics Inc have strong EBITDA marginsTreasury Yields & Weekly Watchlist for Hot Stocks - baoquankhu1.vn

Apr 01, 2026
pulisher
Apr 01, 2026

US Market Wrap: Is CytomX Therapeutics Inc a good stock for dollar cost averaging2026 Breakouts & Breakdowns & Weekly Setup with High ROI Potential - baoquankhu1.vn

Apr 01, 2026
pulisher
Apr 01, 2026

CTMX Technical Analysis & Stock Price Forecast - Intellectia AI

Apr 01, 2026
pulisher
Mar 31, 2026

CytomX Therapeutics launches $250M public offering - MSN

Mar 31, 2026
pulisher
Mar 31, 2026

CytomX Therapeutics gears up for Q4 print; here are the recent forecast changes from Wall Street's most accurate analysts - MSN

Mar 31, 2026
pulisher
Mar 30, 2026

Aug Fed Impact: What hedge funds are buying CytomX Therapeutics Inc2026 Short Interest & Precise Swing Trade Entry Alerts - baoquankhu1.vn

Mar 30, 2026
pulisher
Mar 28, 2026

CTMX stock rallies on strong phase I colorectal cancer study data - MSN

Mar 28, 2026
pulisher
Mar 28, 2026

Performance Recap: Is CytomX Therapeutics Inc stock showing strong momentum2026 Top Gainers & Safe Investment Capital Preservation Plans - baoquankhu1.vn

Mar 28, 2026

Cytomx Therapeutics Inc (CTMX) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$54.26
price up icon 2.69%
$48.70
price down icon 0.25%
$99.47
price up icon 1.08%
$152.54
price up icon 3.76%
$146.74
price down icon 4.34%
ONC ONC
$319.94
price up icon 3.21%
大文字化:     |  ボリューム (24 時間):